Coverage
Filings
Danish biosolutions company Novonesis on Thursday raised its full-year sales forecast after reporting strong growth for the first nine months of the year, citing a robust performance across its markets.
Novonesis on Wednesday laid out new long-term financial targets, aiming to accelerate sales growth and expand profit margins through 2030 as part of its new ‘GROW’ strategy.
Novonesis has successfully completed its acquisition of dsm-firmenich's share of the Feed Enzyme Alliance, the company announced.
| 31 Jan 2019 |
| Group financial statement for 2018 | 24 Jan 2019 |
| Annual report 2018 | 24 Jan 2019 |
| Proposal of candidates to the Board of Directors | 11 Dec 2018 |
| Transactions under Novozymes’ stock buyback program | 29 Nov 2018 |